These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551 [TBL] [Abstract][Full Text] [Related]
6. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467 [TBL] [Abstract][Full Text] [Related]
7. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD; McIntosh SF; Halstead AC Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [TBL] [Abstract][Full Text] [Related]
8. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Spencer K; Bindra R; Cacho AM; Nicolaides KH Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947 [TBL] [Abstract][Full Text] [Related]
10. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
11. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong. Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604 [TBL] [Abstract][Full Text] [Related]
12. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229 [TBL] [Abstract][Full Text] [Related]
13. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population]. Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315 [TBL] [Abstract][Full Text] [Related]
15. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women. Sritippayawan S; Vachirasrisoontra C J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246 [TBL] [Abstract][Full Text] [Related]
16. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening. Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324 [TBL] [Abstract][Full Text] [Related]
17. Multiple marker screening for Down syndrome in twin pregnancies. Neveux LM; Palomaki GE; Knight GJ; Haddow JE Prenat Diagn; 1996 Jan; 16(1):29-34. PubMed ID: 8821849 [TBL] [Abstract][Full Text] [Related]
18. Cell-free fetal DNA levels in pregnancies conceived by IVF. Pan PD; Peter I; Lambert-Messerlian GM; Canick JA; Bianchi DW; Johnson KL Hum Reprod; 2005 Nov; 20(11):3152-6. PubMed ID: 16006472 [TBL] [Abstract][Full Text] [Related]
19. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers. Wald NJ; Morris JK; Ibison J; Wu T; George LM Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087 [TBL] [Abstract][Full Text] [Related]
20. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases. Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]